Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Air as a Placebo for Respiratory Performance in COPD
NCT05218564Unknown
- Sponsor
- Fondazione Don Carlo Gnocchi
- Start
- Feb 2020
- Primary completion
- Mar 2022
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, single-blind trial of oxygen in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Fondazione Don Carlo Gnocchi. Primary endpoint: Metres covered during 6 Minute Walking Test up to 1.5 hours. Status: unknown.
02
Drugs
oxygen
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05218564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05218564.